vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Perma-Pipe International Holdings, Inc. (PPIH). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $61.1M, roughly 1.2× Perma-Pipe International Holdings, Inc.). On growth, Perma-Pipe International Holdings, Inc. posted the faster year-over-year revenue change (47.1% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $12.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 23.4%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Perma-Pipe International Holdings, Inc. designs, manufactures and supplies pre-insulated piping systems and integrated leak detection solutions. Its offerings cater to oil & gas, district heating and cooling, industrial, and municipal infrastructure segments, with a global footprint spanning North America, the Middle East, Europe and Asia.
PBYI vs PPIH — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $61.1M |
| Net Profit | — | $6.3M |
| Gross Margin | 69.3% | 34.4% |
| Operating Margin | 22.7% | 18.6% |
| Net Margin | — | 10.3% |
| Revenue YoY | 27.7% | 47.1% |
| Net Profit YoY | — | 153.5% |
| EPS (diluted) | $0.26 | $0.77 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $61.1M | ||
| Q3 25 | $54.5M | $47.9M | ||
| Q2 25 | $52.4M | $46.7M | ||
| Q1 25 | $46.0M | $45.0M | ||
| Q4 24 | $59.1M | $41.6M | ||
| Q3 24 | $80.5M | $37.5M | ||
| Q2 24 | $47.1M | $34.3M | ||
| Q1 24 | $43.8M | $40.2M |
| Q4 25 | — | $6.3M | ||
| Q3 25 | $8.8M | $851.0K | ||
| Q2 25 | $5.9M | $5.0M | ||
| Q1 25 | $3.0M | $1.8M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $20.3M | $3.3M | ||
| Q2 24 | $-4.5M | $1.4M | ||
| Q1 24 | $-4.8M | $8.6M |
| Q4 25 | 69.3% | 34.4% | ||
| Q3 25 | 77.7% | 30.1% | ||
| Q2 25 | 76.5% | 35.8% | ||
| Q1 25 | 77.1% | 33.7% | ||
| Q4 24 | 76.4% | 33.9% | ||
| Q3 24 | 63.9% | 35.9% | ||
| Q2 24 | 77.4% | 30.6% | ||
| Q1 24 | 75.5% | 30.0% |
| Q4 25 | 22.7% | 18.6% | ||
| Q3 25 | 17.6% | 6.7% | ||
| Q2 25 | 12.7% | 16.9% | ||
| Q1 25 | 8.7% | 12.1% | ||
| Q4 24 | 22.6% | 13.4% | ||
| Q3 24 | 27.4% | 16.4% | ||
| Q2 24 | -4.6% | 9.1% | ||
| Q1 24 | -5.3% | 11.3% |
| Q4 25 | — | 10.3% | ||
| Q3 25 | 16.2% | 1.8% | ||
| Q2 25 | 11.2% | 10.6% | ||
| Q1 25 | 6.5% | 3.9% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | 25.2% | 8.8% | ||
| Q2 24 | -9.6% | 4.2% | ||
| Q1 24 | -11.0% | 21.5% |
| Q4 25 | $0.26 | $0.77 | ||
| Q3 25 | $0.17 | $0.10 | ||
| Q2 25 | $0.12 | $0.61 | ||
| Q1 25 | $0.06 | $0.23 | ||
| Q4 24 | $0.40 | $0.31 | ||
| Q3 24 | $0.41 | $0.40 | ||
| Q2 24 | $-0.09 | $0.18 | ||
| Q1 24 | $-0.10 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $27.2M |
| Total DebtLower is stronger | $22.7M | $12.7M |
| Stockholders' EquityBook value | $130.3M | $85.8M |
| Total Assets | $216.3M | $217.0M |
| Debt / EquityLower = less leverage | 0.17× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $27.2M | ||
| Q3 25 | $94.4M | $17.3M | ||
| Q2 25 | $96.0M | $18.8M | ||
| Q1 25 | $93.2M | $15.7M | ||
| Q4 24 | $101.0M | $13.3M | ||
| Q3 24 | $96.7M | $9.5M | ||
| Q2 24 | $96.8M | $7.7M | ||
| Q1 24 | $107.2M | $5.8M |
| Q4 25 | $22.7M | $12.7M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $15.2M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | $15.2M |
| Q4 25 | $130.3M | $85.8M | ||
| Q3 25 | $115.3M | $80.2M | ||
| Q2 25 | $104.7M | $77.9M | ||
| Q1 25 | $97.1M | $72.1M | ||
| Q4 24 | $92.1M | $71.2M | ||
| Q3 24 | $71.1M | $68.6M | ||
| Q2 24 | $48.5M | $65.5M | ||
| Q1 24 | $51.0M | $65.7M |
| Q4 25 | $216.3M | $217.0M | ||
| Q3 25 | $202.9M | $189.0M | ||
| Q2 25 | $194.9M | $178.3M | ||
| Q1 25 | $196.2M | $165.2M | ||
| Q4 24 | $213.3M | $160.7M | ||
| Q3 24 | $220.7M | $157.8M | ||
| Q2 24 | $205.0M | $155.7M | ||
| Q1 24 | $214.1M | $155.7M |
| Q4 25 | 0.17× | 0.15× | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | 0.21× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $17.3M |
| Free Cash FlowOCF − Capex | $14.4M | $12.4M |
| FCF MarginFCF / Revenue | 19.1% | 20.2% |
| Capex IntensityCapex / Revenue | 0.0% | 8.1% |
| Cash ConversionOCF / Net Profit | — | 2.74× |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $17.3M | ||
| Q3 25 | $9.7M | $-2.0M | ||
| Q2 25 | $14.1M | $733.0K | ||
| Q1 25 | $3.6M | $6.0M | ||
| Q4 24 | $15.6M | $5.2M | ||
| Q3 24 | $11.0M | $2.8M | ||
| Q2 24 | $1.0M | $-73.0K | ||
| Q1 24 | $11.2M | $7.1M |
| Q4 25 | $14.4M | $12.4M | ||
| Q3 25 | $9.7M | $-4.6M | ||
| Q2 25 | $14.1M | $-194.0K | ||
| Q1 25 | $3.6M | $4.7M | ||
| Q4 24 | $15.6M | $4.8M | ||
| Q3 24 | $11.0M | $2.2M | ||
| Q2 24 | $1.0M | $-662.0K | ||
| Q1 24 | — | $4.2M |
| Q4 25 | 19.1% | 20.2% | ||
| Q3 25 | 17.7% | -9.6% | ||
| Q2 25 | 26.8% | -0.4% | ||
| Q1 25 | 7.7% | 10.5% | ||
| Q4 24 | 26.4% | 11.6% | ||
| Q3 24 | 13.7% | 5.8% | ||
| Q2 24 | 2.1% | -1.9% | ||
| Q1 24 | — | 10.5% |
| Q4 25 | 0.0% | 8.1% | ||
| Q3 25 | 0.0% | 5.3% | ||
| Q2 25 | 0.0% | 2.0% | ||
| Q1 25 | 0.1% | 2.9% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 1.7% | ||
| Q1 24 | 0.0% | 7.2% |
| Q4 25 | — | 2.74× | ||
| Q3 25 | 1.10× | -2.40× | ||
| Q2 25 | 2.41× | 0.15× | ||
| Q1 25 | 1.21× | 3.42× | ||
| Q4 24 | — | 2.07× | ||
| Q3 24 | 0.54× | 0.86× | ||
| Q2 24 | — | -0.05× | ||
| Q1 24 | — | 0.82× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
